Collect

  • Bone marrow or leukemic blood sample in an EDTA (purple-top) tube.
  • Fresh Tissue 150 mg or 0.5-2.0 cm3 fresh tissue in transport media. Deliver within 24 hours at room temperature.
  • Fresh Frozen Tissue 150 mg or 0.5-2.0 cm3 tissue snap frozen at -20°C. Store at -20°C. Ship on minimum of 10 lbs. of dry ice in an insulated container by overnight courier.
  • FFPE preferred sample: minimum three 20-um scrolls or 5 slides that are freshly cut before shipping to us via overnight delivery. It would be best to cut and ship Monday to be delivered to us on Tuesday. Alternatively, a whole FFPE block can be sent.

Unacceptable Conditions

Heparinized specimens, severely hemolyzed specimens, frozen, clotted or possibly commingled specimens, blood in non-sterile or leaky containers, mislabeled or inappropriately labeled specimens.

Storage/Transport Temperature

For CHOP Phlebotomy: Samples can be collected throughout the week. Samples collected on weekends or holidays are held in Central Labs and sent to the Genomic Diagnostic Lab the following business day. 

For External Clients: Refrigerate sample until shipment. Send the sample at room temperature with overnight delivery for receipt Monday through Friday, optimally within 24 hours of collection.

Please contact the lab (267-426-1447) with questions regarding non-blood specimens.

Volume Required

3-5 mL

Minimum Required

2 mL

Phlebotomy Draw

Yes

Performing Lab

Division of Genomic Diagnostics

Performed

Monday-Friday 9:00am - 4:00pm

Reported

21 days

Detection Rate

The Hematological Cancer Panel V2.3 includes sequence and copy number analyses of 117 cancer genes and two genes associated with cancer pharmacogenomics. 

Utility

Facilitates disease diagnosis, risk stratification, and therapeutic decision-making.

Synonyms

  • Somatic Leukemia Panel, Somatic Lymphoma Panel
  • HEMEP
  • ABL1, ASXL1, ASXL2, ATRX, BCL11B, BCL6, BCOR, BCORL1, BRAF, BRINP3, CALR, CBL, CCND3, CD79A, CD79B, CDC25C, CDKN2A, CDKN2B, CEBPA, CREBBP, CRLF2, CSF1R, CSF3R, CTCF, DDX41, DNM2, DNMT1, DNMT3A, DOT1L, EBF1, EED, ELANE, EP300, EPOR, ERG, ESR1, ETNK1, ETS1, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GATA3, HNRNPK, HRAS, IDH1, IDH2, IKZF1, IKZF3, IL7R, JAK1, JAK2, JAK3, KDM6A, KIT, KMT2A, KMT2C, KMT2D, KRAS, LEF1, LYL1
  • MAP2K1, MPL, MSH2, MSH6, MYB, MYD88, NF1, NOTCH1, NPM1, NRAS, NSD1, NSD2 (WHSC1), NT5C2, PAX5, PDGFRA, PHF6, PIK3R1, PRPF40B, PRPF8, PTEN, PTPN11, RAD21, RB1, RELN, RPL10, RTEl1, RUNX1, SETBP1, SETD2, SF1, SF3A1, SF3B1, SH2B3, SMC1A, SMC3, SRSF2, STAG2, STAT3, SUZ12, TAL1, TCF3, TERT, TET2, TINF2, TLX1, TLX3, TP53, U2AF1, U2AF2, UBA2, USH2A, USP7, WT1, ZRSR2
  • Hematologic, Heme, Hematologic Panel, Heme Panel, Hematologic Cancer Panel, Heme Cancer Panel

LIS Mnemonic

HEMEP

Available STAT

Yes

Test Notes

Next generation sequencing (NGS) and data analysis: Genomic DNA is extracted from the patient’s sample following standard DNA extraction protocols. Extracted DNA is fragmented and tagged using SureSelect QXT target enrichment to generate adapter-tagged libraries. Biotin-labeled probes specific to the targeted regions are used for capture hybridization. Libraries are enriched for the desired regions using streptavidin beads. Enriched libraries are then indexed and pooled for sequencing. Libraries are subject to sequence analysis on Illumina NovaSeq 6000 system for 150 bp paired end reads. All coding exons and the flanking intron sequences of targeted genes in the panel are sequenced, and selected promoter regions and known intronic mutations are also evaluated. Sequence data are analyzed using the home brew software ConcordS V4.0.0 and NextGENe V2 NGS Analysis Software. Sequence variants within exons and 5 bp flanking intron sequences are annotated. Copy number variation (CNV) analysis for gross deletions and duplications are evaluated using NGS data. Clinically significant variants including single nucleotide variants (SNVs), indels, and CNVs are confirmed by Sanger sequencing, MLPA, Real-Time PCR, or ddPCR only when necessary.

Molecular Testing Notes

The genes included in the V2.3 Hematologic Cancer Panel (GRCh38): ABL1, ASXL1, ASXL2, ATRX, BCL11B, BCL6, BCOR, BCORL1, BRAF, BRINP3, CALR, CBL, CCND3, CD79A, CD79B, CDC25C, CDKN2A, CDKN2B, CEBPA, CREBBP, CRLF2, CSF1R, CSF3R, CTCF, DDX41, DNM2, DNMT1, DNMT3A, DOT1L, EBF1, EED, ELANE, EP300, EPOR, ERG, ESR1, ETNK1, ETS1, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GATA3, HNRNPK, HRAS, IDH1, IDH2, IKZF1, IKZF3, IL7R, JAK1, JAK2, JAK3, KDM6A, KIT, KMT2A, KMT2C, KMT2D, KRAS, LEF1, LYL1, MAP2K1, MPL, MSH2, MSH6, MYB, MYD88, NF1, NOTCH1, NPM1, NRAS, NSD1, NSD2 (WHSC1), NT5C2, PAX5, PDGFRA, PHF6, PIK3R1, PRPF40B, PRPF8, PTEN, PTPN11, RAD21, RB1, RELN, RPL10, RTEl1, RUNX1, SETBP1, SETD2, SF1, SF3A1, SF3B1, SH2B3, SMC1A, SMC3, SRSF2, STAG2, STAT3, SUZ12, TAL1, TCF3, TERT, TET2, TINF2, TLX1, TLX3, TP53, U2AF1, U2AF2, UBA2, USH2A, USP7, WT1, ZRSR2; and two cancer-associated pharmacogenomics genes: NUDT15 and TPMT.

CPT Codes

81455
Collection

Collect

  • Bone marrow or leukemic blood sample in an EDTA (purple-top) tube.
  • Fresh Tissue 150 mg or 0.5-2.0 cm3 fresh tissue in transport media. Deliver within 24 hours at room temperature.
  • Fresh Frozen Tissue 150 mg or 0.5-2.0 cm3 tissue snap frozen at -20°C. Store at -20°C. Ship on minimum of 10 lbs. of dry ice in an insulated container by overnight courier.
  • FFPE preferred sample: minimum three 20-um scrolls or 5 slides that are freshly cut before shipping to us via overnight delivery. It would be best to cut and ship Monday to be delivered to us on Tuesday. Alternatively, a whole FFPE block can be sent.

Unacceptable Conditions

Heparinized specimens, severely hemolyzed specimens, frozen, clotted or possibly commingled specimens, blood in non-sterile or leaky containers, mislabeled or inappropriately labeled specimens.

Storage/Transport Temperature

For CHOP Phlebotomy: Samples can be collected throughout the week. Samples collected on weekends or holidays are held in Central Labs and sent to the Genomic Diagnostic Lab the following business day. 

For External Clients: Refrigerate sample until shipment. Send the sample at room temperature with overnight delivery for receipt Monday through Friday, optimally within 24 hours of collection.

Please contact the lab (267-426-1447) with questions regarding non-blood specimens.

Volume Required

3-5 mL

Minimum Required

2 mL

Phlebotomy Draw

Yes
Ordering

Performing Lab

Division of Genomic Diagnostics

Performed

Monday-Friday 9:00am - 4:00pm

Reported

21 days

Detection Rate

The Hematological Cancer Panel V2.3 includes sequence and copy number analyses of 117 cancer genes and two genes associated with cancer pharmacogenomics. 

Utility

Facilitates disease diagnosis, risk stratification, and therapeutic decision-making.

Synonyms

  • Somatic Leukemia Panel, Somatic Lymphoma Panel
  • HEMEP
  • ABL1, ASXL1, ASXL2, ATRX, BCL11B, BCL6, BCOR, BCORL1, BRAF, BRINP3, CALR, CBL, CCND3, CD79A, CD79B, CDC25C, CDKN2A, CDKN2B, CEBPA, CREBBP, CRLF2, CSF1R, CSF3R, CTCF, DDX41, DNM2, DNMT1, DNMT3A, DOT1L, EBF1, EED, ELANE, EP300, EPOR, ERG, ESR1, ETNK1, ETS1, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GATA3, HNRNPK, HRAS, IDH1, IDH2, IKZF1, IKZF3, IL7R, JAK1, JAK2, JAK3, KDM6A, KIT, KMT2A, KMT2C, KMT2D, KRAS, LEF1, LYL1
  • MAP2K1, MPL, MSH2, MSH6, MYB, MYD88, NF1, NOTCH1, NPM1, NRAS, NSD1, NSD2 (WHSC1), NT5C2, PAX5, PDGFRA, PHF6, PIK3R1, PRPF40B, PRPF8, PTEN, PTPN11, RAD21, RB1, RELN, RPL10, RTEl1, RUNX1, SETBP1, SETD2, SF1, SF3A1, SF3B1, SH2B3, SMC1A, SMC3, SRSF2, STAG2, STAT3, SUZ12, TAL1, TCF3, TERT, TET2, TINF2, TLX1, TLX3, TP53, U2AF1, U2AF2, UBA2, USH2A, USP7, WT1, ZRSR2
  • Hematologic, Heme, Hematologic Panel, Heme Panel, Hematologic Cancer Panel, Heme Cancer Panel

LIS Mnemonic

HEMEP

Available STAT

Yes

Test Notes

Next generation sequencing (NGS) and data analysis: Genomic DNA is extracted from the patient’s sample following standard DNA extraction protocols. Extracted DNA is fragmented and tagged using SureSelect QXT target enrichment to generate adapter-tagged libraries. Biotin-labeled probes specific to the targeted regions are used for capture hybridization. Libraries are enriched for the desired regions using streptavidin beads. Enriched libraries are then indexed and pooled for sequencing. Libraries are subject to sequence analysis on Illumina NovaSeq 6000 system for 150 bp paired end reads. All coding exons and the flanking intron sequences of targeted genes in the panel are sequenced, and selected promoter regions and known intronic mutations are also evaluated. Sequence data are analyzed using the home brew software ConcordS V4.0.0 and NextGENe V2 NGS Analysis Software. Sequence variants within exons and 5 bp flanking intron sequences are annotated. Copy number variation (CNV) analysis for gross deletions and duplications are evaluated using NGS data. Clinically significant variants including single nucleotide variants (SNVs), indels, and CNVs are confirmed by Sanger sequencing, MLPA, Real-Time PCR, or ddPCR only when necessary.

Molecular Testing Notes

The genes included in the V2.3 Hematologic Cancer Panel (GRCh38): ABL1, ASXL1, ASXL2, ATRX, BCL11B, BCL6, BCOR, BCORL1, BRAF, BRINP3, CALR, CBL, CCND3, CD79A, CD79B, CDC25C, CDKN2A, CDKN2B, CEBPA, CREBBP, CRLF2, CSF1R, CSF3R, CTCF, DDX41, DNM2, DNMT1, DNMT3A, DOT1L, EBF1, EED, ELANE, EP300, EPOR, ERG, ESR1, ETNK1, ETS1, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GATA3, HNRNPK, HRAS, IDH1, IDH2, IKZF1, IKZF3, IL7R, JAK1, JAK2, JAK3, KDM6A, KIT, KMT2A, KMT2C, KMT2D, KRAS, LEF1, LYL1, MAP2K1, MPL, MSH2, MSH6, MYB, MYD88, NF1, NOTCH1, NPM1, NRAS, NSD1, NSD2 (WHSC1), NT5C2, PAX5, PDGFRA, PHF6, PIK3R1, PRPF40B, PRPF8, PTEN, PTPN11, RAD21, RB1, RELN, RPL10, RTEl1, RUNX1, SETBP1, SETD2, SF1, SF3A1, SF3B1, SH2B3, SMC1A, SMC3, SRSF2, STAG2, STAT3, SUZ12, TAL1, TCF3, TERT, TET2, TINF2, TLX1, TLX3, TP53, U2AF1, U2AF2, UBA2, USH2A, USP7, WT1, ZRSR2; and two cancer-associated pharmacogenomics genes: NUDT15 and TPMT.
Result Interpretation
Administrative

CPT Codes

81455